Wellington Management Group’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Wellington Management Group's DFTX Position: Q3 2026 in Review
Wellington Management Group increased its Definium Therapeutics (DFTX) stake by 24% in Q3 2026, buying an estimated $30.4M and bringing the position to 3,671,887 shares worth $140M. The position accounts for 0.02% of the portfolio, ranked #454.
Wellington Management Group first reported a position in DFTX in Q1 2024 and has held it in 11 quarters since. 270 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Wellington Management Group held 3,671,887 shares of Definium Therapeutics worth $140M as of Q3 2026.
- Wellington Management Group bought 722,153 Definium Therapeutics shares in Q3 2026, an estimated $30.4M.
- Definium Therapeutics made up 0.02% of Wellington Management Group's portfolio in Q3 2026, its #454 holding.
- Wellington Management Group first reported a position in Definium Therapeutics in Q1 2024 and has held it in 11 quarters since.
- 270 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.